A Phase 1 Study of S-637880 - Investigation of the effects of multiple doses, and the drug-drug interaction with midazolam
Phase 1
Completed
- Conditions
- Healthy adult subjects
- Registration Number
- JPRN-jRCT2080225143
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Healthy adult Japanese or Caucasian, male or female subjects
Exclusion Criteria
Subjects who are considered ineligible for this study by the investigator or subinvestigator due to history of metabolic, endocrine, hepatic, renal, pulmonary, hematological, cardiovascular, gastrointestinal, urological, immune, neurological, or psychiatric disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method